DNA Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Offering (Instruments, Reagents & Kits, and Services & Software), Technology, Specimen, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Mid

DNA Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Offering (Instruments, Reagents & Kits, and Services & Software), Technology, Specimen, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025 - 2034



The global DNA diagnostics market size is expected to reach USD 31.31 billion by 2034, according to a new study by Polaris Market Research. The report “DNA Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Offering (Instruments, Reagents & Kits, and Services & Software), Technology, Specimen, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The expansion of the DNA diagnostics market is being driven by the rising prevalence of genetic disorders worldwide. The World Health Organization (WHO) estimated that there are around 10,000 different types of monogenic diseases caused by mutations in a single gene. The global prevalence rate is approximately 10 per 1000 individuals, indicating that between 70 million and 80 million people are affected by genetic disorders. This surge in genetic conditions has created an increased demand for efficient tools to detect and evaluate genetic disorders. Consequently, the growing incidence of rare genetic diseases, hereditary cancers, and inherited metabolic disorders is propelling the advancement of diagnostic technologies, thereby stimulating the DNA diagnostics market.

The market for DNA diagnostics is experiencing significant growth due to the advancements in genomic technology, which have improved the accuracy, speed, and affordability of genetic testing. For instance, in May 2024, BioAro, a genomic research and technology company, launched PanOmiQ, a software that provides real-time insights into the complexities of the human genome. These types of technological enhancements facilitate in-depth genome analysis, resulting in more detailed and dependable diagnostic outcomes. Thus, the ongoing evolution of genomic technologies is driving the growth of the DNA diagnostics market by supporting the development of new diagnostic tools and methods.

Healthcare firms are escalating their financial investments to drive innovation, research, and the advancement of new diagnostic technologies. These investments are empowering companies to progress genomic research, refine testing methodologies, and enhance the precision and dependability of DNA diagnostics. Consequently, company investments are accelerating collaborations with research institutions and the integration of genetic testing into healthcare practices, thereby stimulating the expansion of the global DNA diagnostics market.

DNA Diagnostics Market Report Highlights

The reagents and kits segment is expected to grow with a substantial CAGR in the global market, driven by the development of comprehensive suites tailored for genetic testing.

In 2023, the cancer genetics tests segment accounted for the largest market share because of the increasing prevalence of cancer globally.

In 2023, North America dominated the global DNA diagnostics market in terms of revenue due to the presence of well-established institutions and a robust healthcare infrastructure in the region.

The DNA diagnostics market in China is expected to grow substantially because of the country's increasing investment in biotechnology and healthcare infrastructure.

The global key market players are Abbott; Agilent Technologies, Inc.; Avalon GloboCare Corp.; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Cepheid; F. Hoffmann-La Roche Ltd; GE HealthCare; Hologic, Inc.; Illumina, Inc.; QIAGEN; Siemens Healthcare Private Limited; and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the DNA diagnostics market report based on offering, technology, specimen, application, end user, and region:

By Offering Outlook (Revenue - USD Billion, 2019 - 2032)
  • Instruments
  • Reagents & Kits
  • Services & Software
By Technology Outlook (Revenue - USD Billion, 2019 - 2032)
  • In Situ Hybridization
  • Mass Spectroscopy
  • Microarrays
  • Polymerase Chain Reaction (PCR)
  • Sequencing
  • Others
By Specimen Outlook (Revenue - USD Billion, 2019 - 2032)
  • Blood, Serum, and Plasma
  • Urine
  • Others
By Application Outlook (Revenue - USD Billion, 2019 - 2032)
  • Cancer Genetics Tests
  • Infectious Diseases DNA Testing
  • CT/NG Diagnostic
  • HBV Diagnostic
  • HCV Diagnostic
  • HIV Diagnostic
  • HPV Diagnostic
  • MRSA Diagnostic
  • TB Diagnostic
  • Others
  • Newborn Genetic Screening
  • Preimplantation & Reproductive Diagnosis
  • Non-Infectious Diseases DNA Testing
  • Cardiovascular Diseases
  • CNS & PNS Related
  • Lung, Kidney, Liver & GT Related
  • Sensory Diseases
  • Skeletal, Connective, Ectodermal & Dermal DNA Testing
  • Hematology & Immunology/Identity Diagnostics & Forensics
  • Pharmacogenomics/Drug Metabolism
  • Prenatal DNA Carrier Screening
  • Others
By End User Outlook (Revenue - USD Billion, 2019 - 2032)
  • Diagnostic laboratories
  • Hospitals & clinics
  • Others
By Regional Outlook (Revenue - USD Billion, 2019 - 2032)
  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA


1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global DNA Diagnostics Market Insights
4.1. DNA Diagnostics Market – Market Snapshot
4.2. DNA Diagnostics Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Expansion of DNA Testing Services Are Driving Market Growth
4.2.1.2. Investments by Healthcare Companies Are Propelling Market Size
4.2.2. Restraints and Challenges
4.2.2.1. Stringent Regulatory Requirements Affects the Market Expansion
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. DNA Diagnostics Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global DNA Diagnostics Market, by Offering
5.1. Key Findings
5.2. Introduction
5.2.1. Global DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
5.3. Instruments
5.3.1. Global DNA Diagnostics Market, by Instruments, by Region, 2020-2034 (USD billion)
5.4. Reagents & Kits
5.4.1. Global DNA Diagnostics Market, by Reagents & Kits, by Region, 2020-2034 (USD billion)
5.5. Services & Software
5.5.1. Global DNA Diagnostics Market, by Services & Software, by Region, 2020-2034 (USD billion)
6. Global DNA Diagnostics Market, by Technology
6.1. Key Findings
6.2. Introduction
6.2.1. Global DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
6.3. In Situ Hybridization
6.3.1. Global DNA Diagnostics Market, by In Situ Hybridization, by Region, 2020-2034 (USD billion)
6.4. Mass Spectroscopy
6.4.1. Global DNA Diagnostics Market, by Mass Spectroscopy, by Region, 2020-2034 (USD billion)
6.5. Microarrays
6.5.1. Global DNA Diagnostics Market, by Microarrays, by Region, 2020-2034 (USD billion)
6.6. Polymerase Chain Reaction (PCR)
6.6.1. Global DNA Diagnostics Market, by Polymerase Chain Reaction (PCR), by Region, 2020-2034 (USD billion)
6.7. Sequencing
6.7.1. Global DNA Diagnostics Market, by Sequencing, by Region, 2020-2034 (USD billion)
6.8. Others
6.8.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)
7. Global DNA Diagnostics Market, by Specimen
7.1. Key Findings
7.2. Introduction
7.2.1. Global DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
7.3. Blood, Serum, and Plasma
7.3.1. Global DNA Diagnostics Market, by Blood, Serum, and Plasma, by Region, 2020-2034 (USD billion)
7.4. Urine
7.4.1. Global DNA Diagnostics Market, by Urine, by Region, 2020-2034 (USD billion)
7.5. Others
7.5.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)
8. Global DNA Diagnostics Market, by Application
8.1. Key Findings
8.2. Introduction
8.2.1. Global DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
8.3. Cancer Genetics Tests
8.3.1. Global DNA Diagnostics Market, by Cancer Genetics Tests, by Region, 2020-2034 (USD billion)
8.4. Infectious Diseases DNA Testing
8.4.1. Global DNA Diagnostics Market, by Infectious Diseases DNA Testing, by Region, 2020-2034 (USD billion)
8.4.2. CT/NG Diagnostic
8.4.2.1. Global DNA Diagnostics Market, by CT/NG Diagnostic, by Region, 2020-2034 (USD billion)
8.4.3. HBV Diagnostic
8.4.3.1. Global DNA Diagnostics Market, by HBV Diagnostic, by Region, 2020-2034 (USD billion)
8.4.4. HCV Diagnostic
8.4.4.1. Global DNA Diagnostics Market, by HCV Diagnostic, by Region, 2020-2034 (USD billion)
8.4.5. HIV Diagnostic
8.4.5.1. Global DNA Diagnostics Market, by HIV Diagnostic, by Region, 2020-2034 (USD billion)
8.4.6. HPV Diagnostic
8.4.6.1. Global DNA Diagnostics Market, by HPV Diagnostic, by Region, 2020-2034 (USD billion)
8.4.7. MRSA Diagnostic
8.4.7.1. Global DNA Diagnostics Market, by MRSA Diagnostic, by Region, 2020-2034 (USD billion)
8.4.8. TB Diagnostic
8.4.8.1. Global DNA Diagnostics Market, by TB Diagnostic, by Region, 2020-2034 (USD billion)
8.4.9. Others
8.4.9.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)
8.5. Newborn Genetic Screening
8.5.1. Global DNA Diagnostics Market, by Newborn Genetic Screeningc, by Region, 2020-2034 (USD billion)
8.6. Preimplantation & Reproductive Diagnosis
8.6.1. Global DNA Diagnostics Market, by Preimplantation & Reproductive Diagnosis, by Region, 2020-2034 (USD billion)
8.7. Non-Infectious Diseases DNA Testing
8.7.1. Global DNA Diagnostics Market, by Non-Infectious Diseases DNA Testing, by Region, 2020-2034 (USD billion)
8.7.2. Cardiovascular Diseases
8.7.2.1. Global DNA Diagnostics Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD billion)
8.7.3. CNS & PNS Related
8.7.3.1. Global DNA Diagnostics Market, by CNS & PNS Related, by Region, 2020-2034 (USD billion)
8.7.4. Lung, Kidney, Liver & GT Related
8.7.4.1. Global DNA Diagnostics Market, by Lung, Kidney, Liver & GT Related, by Region, 2020-2034 (USD billion)
8.7.5. Sensory Diseases
8.7.5.1. Global DNA Diagnostics Market, by Sensory Diseases, by Region, 2020-2034 (USD billion)
8.7.6. Skeletal, Connective, Ectodermal & Dermal DNA Testing
8.7.6.1. Global DNA Diagnostics Market, by Skeletal, Connective, Ectodermal & Dermal DNA Testing, by Region, 2020-2034 (USD billion)
8.8. Hematology & Immunology/Identity Diagnostics & Forensics
8.8.1. Global DNA Diagnostics Market, by Hematology & Immunology/Identity Diagnostics & Forensics, by Region, 2020-2034 (USD billion)
8.9. Pharmacogenomics/Drug Metabolism
8.9.1. Global DNA Diagnostics Market, by Pharmacogenomics/Drug Metabolism, by Region, 2020-2034 (USD billion)
8.10. Prenatal DNA Carrier Screening
8.10.1. Global DNA Diagnostics Market, by Prenatal DNA Carrier Screening, by Region, 2020-2034 (USD billion)
8.11. Others
8.11.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)
9. Global DNA Diagnostics Market, by End User
9.1. Key Findings
9.2. Introduction
9.2.1. Global DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
9.3. Diagnostic Laboratories
9.3.1. Global DNA Diagnostics Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD billion)
9.4. Hospitals & clinics
9.4.1. Global DNA Diagnostics Market, by Hospitals & clinics, by Region, 2020-2034 (USD billion)
9.5. Others
9.5.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)
10. Global DNA Diagnostics Market, by Geography
10.1. Key Findings
10.2. Introduction
10.2.1. DNA Diagnostics Market Assessment, By Geography, 2020-2034 (USD billion)
10.3. DNA Diagnostics Market – North America
10.3.1. North America: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.3.2. North America: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.3.3. North America: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.3.4. North America: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.3.5. North America: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.3.6. North America: XX
10.3.7. DNA Diagnostics Market – U.S.
10.3.7.1. U.S.: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.3.7.2. U.S.: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.3.7.3. U.S.: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.3.7.4. U.S.: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.3.7.5. U.S.: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.3.8. DNA Diagnostics Market – Canada
10.3.8.1. Canada: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.3.8.2. Canada: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.3.8.3. Canada: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.3.8.4. Canada: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.3.8.5. Canada: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.4. DNA Diagnostics Market – Europe
10.4.1. Europe: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.4.2. Europe: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.4.3. Europe: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.4.4. Europe: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.4.5. Europe: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.4.6. DNA Diagnostics Market – UK
10.4.6.1. UK: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.4.6.2. UK: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.4.6.3. UK: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.4.6.4. UK: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.4.6.5. UK: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.4.7. DNA Diagnostics Market – France
10.4.7.1. France: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.4.7.2. France: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.4.7.3. France: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.4.7.4. France: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.4.7.5. France: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.4.8. DNA Diagnostics Market – Germany
10.4.8.1. Germany: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.4.8.2. Germany: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.4.8.3. Germany: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.4.8.4. Germany: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.4.8.5. Germany: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.4.9. DNA Diagnostics Market – Italy
10.4.9.1. Italy: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.4.9.2. Italy: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.4.9.3. Italy: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.4.9.4. Italy: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.4.9.5. Italy: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.4.10. DNA Diagnostics Market – Spain
10.4.10.1. Spain: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.4.10.2. Spain: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.4.10.3. Spain: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.4.10.4. Spain: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.4.10.5. Spain: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.4.11. DNA Diagnostics Market – Netherlands
10.4.11.1. Netherlands: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.4.11.2. Netherlands: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.4.11.3. Netherlands: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.4.11.4. Netherlands: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.4.11.5. Netherlands: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.4.12. DNA Diagnostics Market – Russia
10.4.12.1. Russia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.4.12.2. Russia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.4.12.3. Russia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.4.12.4. Russia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.4.12.5. Russia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.4.13. DNA Diagnostics Market – Rest of Europe
10.4.13.1. Rest of Europe: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.4.13.2. Rest of Europe: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.4.13.3. Rest of Europe: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.4.13.4. Rest of Europe: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.4.13.5. Rest of Europe: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.5. DNA Diagnostics Market – Asia Pacific
10.5.1. Asia Pacific: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.5.2. Asia Pacific: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.5.3. Asia Pacific: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.5.4. Asia Pacific: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.5.5. Asia Pacific: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.5.6. DNA Diagnostics Market – China
10.5.6.1. China: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.5.6.2. China: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.5.6.3. China: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.5.6.4. China: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.5.6.5. China: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.5.7. DNA Diagnostics Market – India
10.5.7.1. India: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.5.7.2. India: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.5.7.3. India: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.5.7.4. India: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.5.7.5. India: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.5.8. DNA Diagnostics Market – Malaysia
10.5.8.1. Malaysia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.5.8.2. Malaysia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.5.8.3. Malaysia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.5.8.4. Malaysia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.5.8.5. Malaysia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.5.9. DNA Diagnostics Market – Japan
10.5.9.1. Japan: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.5.9.2. Japan: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.5.9.3. Japan: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.5.9.4. Japan: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.5.9.5. Japan: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.5.10. DNA Diagnostics Market – Indonesia
10.5.10.1. Indonesia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.5.10.2. Indonesia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.5.10.3. Indonesia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.5.10.4. Indonesia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.5.10.5. Indonesia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.5.11. DNA Diagnostics Market – South Korea
10.5.11.1. South Korea: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.5.11.2. South Korea: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.5.11.3. South Korea: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.5.11.4. South Korea: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.5.11.5. South Korea: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.5.12. DNA Diagnostics Market – Australia
10.5.12.1. Australia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.5.12.2. Australia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.5.12.3. Australia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.5.12.4. Australia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.5.12.5. Australia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.5.13. DNA Diagnostics Market – Rest of Asia Pacific
10.5.13.1. Rest of Asia Pacific: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.5.13.2. Rest of Asia Pacific: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.5.13.3. Rest of Asia Pacific: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.5.13.4. Rest of Asia Pacific: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.5.13.5. Rest of Asia Pacific: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.6. DNA Diagnostics Market – Middle East & Africa
10.6.1. Middle East & Africa: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.6.2. Middle East & Africa: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.6.3. Middle East & Africa: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.6.4. Middle East & Africa: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.6.5. Middle East & Africa: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.6.6. DNA Diagnostics Market – Saudi Arabia
10.6.6.1. Saudi Arabia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.6.6.2. Saudi Arabia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.6.6.3. Saudi Arabia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.6.6.4. Saudi Arabia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.6.6.5. Saudi Arabia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.6.7. DNA Diagnostics Market – UAE
10.6.7.1. UAE: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.6.7.2. UAE: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.6.7.3. UAE: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.6.7.4. UAE: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.6.7.5. UAE: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.6.8. DNA Diagnostics Market – Israel
10.6.8.1. Israel: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.6.8.2. Israel: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.6.8.3. Israel: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.6.8.4. Israel: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.6.8.5. Israel: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.6.9. DNA Diagnostics Market – South Africa
10.6.9.1. South Africa: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.6.9.2. South Africa: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.6.9.3. South Africa: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.6.9.4. South Africa: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.6.9.5. South Africa: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.6.10. DNA Diagnostics Market – Rest of Middle East & Africa
10.6.10.1. Rest of Middle East & Africa: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.6.10.2. Rest of Middle East & Africa: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.6.10.3. Rest of Middle East & Africa: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.6.10.4. Rest of Middle East & Africa: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.6.10.5. Rest of Middle East & Africa: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.7. DNA Diagnostics Market – Latin America
10.7.1. Latin America: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.7.2. Latin America: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.7.3. Latin America: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.7.4. Latin America: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.7.5. Latin America: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.7.6. DNA Diagnostics Market – Mexico
10.7.6.1. Mexico: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.7.6.2. Mexico: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.7.6.3. Mexico: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.7.6.4. Mexico: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.7.6.5. Mexico: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.7.7. DNA Diagnostics Market – Brazil
10.7.7.1. Brazil: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.7.7.2. Brazil: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.7.7.3. Brazil: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.7.7.4. Brazil: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.7.7.5. Brazil: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.7.8. DNA Diagnostics Market – Argentina
10.7.8.1. Argentina: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.7.8.2. Argentina: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.7.8.3. Argentina: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.7.8.4. Argentina: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.7.8.5. Argentina: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
10.7.9. DNA Diagnostics Market – Rest of Latin America
10.7.9.1. Rest of Latin America: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
10.7.9.2. Rest of Latin America: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
10.7.9.3. Rest of Latin America: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
10.7.9.4. Rest of Latin America: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
10.7.9.5. Rest of Latin America: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
11. Competitive Landscape
11.1. Expansion and Acquisition Analysis
11.1.1. Expansion
11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
12.1. Abbott
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Benchmarking
12.1.4. Recent Development
12.2. Agilent Technologies, Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Benchmarking
12.2.4. Recent Development
12.3. Avalon GloboCare Corp.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Benchmarking
12.3.4. Recent Development
12.4. Beckman Coulter, Inc.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Benchmarking
12.4.4. Recent Development
12.5. Bio-Rad Laboratories, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Benchmarking
12.5.4. Recent Development
12.6. Cepheidc
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Benchmarking
12.6.4. Recent Development
12.7. F. Hoffmann-La Roche Ltd
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Benchmarking
12.7.4. Recent Development
12.8. GE HealthCare
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Benchmarking
12.8.4. Recent Development
12.9. Hologic, Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Benchmarking
12.9.4. Recent Development
12.10. Illumina, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Benchmarking
12.10.4. Recent Development
12.11. Siemens Healthcare Private Limited
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Benchmarking
12.11.4. Recent Development
12.12. Thermo Fisher Scientific Inc.
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Benchmarking
12.12.4. Recent Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings